The Global Implantable Cardioverter-Defibrillators Market Report Offers A Comprehensive Analysis Of The Market
An implantable cardioverter defibrillator is an electronic device that is implanted and used to treat sudden cardiac arrest and arrhythmia. The device can detect abnormal heart rates and deliver electric shocks to patients if necessary. The rapidly growing geriatric population in many regions around the world is a major driver of the implantable cardioverter defibrillator market. According to Forbes 2019, the number of people aged 65 and up increased by 33% between 2007 and 2017, rising from 37.2 to 49.2 million. The figure is expected to double to 98 million by 2060 if current trends continue. Furthermore, the 85-year-old population is expected to grow by more than 8 million by 2040, driving market growth as more patients require implantable cardioverter defibrillators for treatment.
The growing geriatric population around the world is expected to drive the market growth of implantable cardioverter defibrillators, as people over the age of 65 are more susceptible to cardiovascular diseases and cardiac arrests. According to the United Nations, the geriatric population in the United States was 703 million people in 2019. The number of elderly people is expected to double to 1.5 billion by 2050, fueling market growth as the number of patients requiring implantable cardioverter defibrillators increases.
The rise in cardiovascular diseases, increased applicability of Implantable Cardioverter Defibrillator Devices, and recent advancements in Subcutaneous Implantable Cardioverter Defibrillators are driving market growth. The Global Implantable Cardioverter Defibrillators Market report offers a comprehensive analysis of the market. The report provides an in-depth examination of key segments, trends, drivers, restraints, the competitive landscape, and factors that are important in the market. The Global Implantable Cardioverter Defibrillators Market is divided into four regions: North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific is expected to have the highest CAGR during the forecast period. The factors can be attributed to a large patient population, an increase in the geriatric population, an increase in the incidence of cardiovascular diseases, and a demand for increased battery life in ICD devices, which improved healthcare workflow organisation.
Comments
Post a Comment